Does TeamCare Cover Zepbound in 2026?

Does TeamCare cover Zepbound? Not for weight loss under the three 2026 plan documents we reviewed. They exclude medicines prescribed for weight loss. Caremark's October 1 drug-list change does not itself remove that rule. Sleep-apnea coverage needs a separate check. Zepbound self-pay options start at $299 per 28-day fill, with higher-dose offer prices of $449.

By The RX Index · Independent guidance for choosing your GLP-1 path. Last verified: September 2026 · Public sources checked September 22, 2026

Affiliate disclosure: Some links on this page are affiliate links, marked "(affiliate link)." If you sign up through one, we may earn a commission at no extra cost to you. That never changes what TeamCare's documents say. You can check your own TeamCare benefits for free without buying anything.

Your answer by situation

Sources: the TeamCare evidence map, Zepbound's FDA-approved sleep-apnea use, Mounjaro's prescribing information, Lilly's self-pay terms, and CMS's Bridge rules.

Check my TeamCare rule before I pay → Jump to your Zepbound options without TeamCare ↓

We opened TeamCare's own plan documents and the drug list TeamCare posts for its members. Below you'll find three things:

• the exact weight-loss exclusion and where it appears;
• the sleep-apnea coverage question to ask separately;
• ways to get FDA-approved treatment without adding fees you don't need.

This page is for you if you're covered by TeamCare and want Zepbound, or a pharmacy just rejected it. TeamCare is the Central States, Southeast and Southwest Areas Health and Welfare Fund, the Teamsters' Central States health plan.

This page isn't for you if:

• Your drug coverage is CVS Caremark through a different employer. Read Does CVS Caremark Cover Zepbound? instead.
• You only have Medicare. Go straight to our Medicare GLP-1 Bridge guide.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, whether you want a shot or a pill, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose. It's free, takes about 2 minutes, and needs no signup. The tool can't see your TeamCare account, so your plan still decides coverage.

Get my personalized GLP-1 provider match →

Why won't TeamCare cover Zepbound for weight loss?

Answer: The three 2026 TeamCare plan documents below list medications prescribed for weight loss as not covered under the prescription drug benefit. That is a benefit exclusion, meaning a rule that says the plan won't pay for a whole category of care. If these are your governing terms, the exclusion applies to Zepbound prescribed for weight loss.

Here's the word that matters: exclusion.

• A prior authorization (PA) is a permission request your doctor sends to the plan. Missing records can be fixed, but the request still has to meet the plan's rules.
• An exclusion is a closed door. A PA form alone does not remove it. You can still ask whether the plan applied the right rule to your prescription and use the appeal process in your denial notice.

We read the plan documents TeamCare posts on its Forms & Documents page. Here's what we found and where you can check it yourself.

TeamCare Zepbound Evidence Map (checked September 22, 2026)

Quick definitions:

• Formulary: the drug list a plan uses.
• Pharmacy benefit manager (PBM): the company that runs a plan's drug side. For TeamCare, that's CVS Caremark.

What we didn't review: TeamCare also posts separate plan documents for some groups, such as TForce Freight (Option A) and UPS retirees. We didn't review those. Find your Plan Benefit Profile under My Documents on your MyTeamCare dashboard, then ask which plan document and amendments apply to you. TeamCare's benefits FAQ explains where to find your personal benefit details.

This rule isn't new, and members have felt it

In 2025, WSAW-TV in Wausau, Wisconsin, shared the story of a TeamCare member named Bobbi Birk-LaBarge. She lost 50 pounds on Ozempic. Then her coverage ended, and her cost jumped from $20 a month to more than $1,000.

"I was absolutely devastated," she told the station.

TeamCare declined to tell reporters why. But a TeamCare employee told the station by phone that the plan had stopped covering these drugs when they're used only for weight loss (WSAW, September 23, 2025). Her story concerns Ozempic, not a Zepbound claim.

Her story has a second lesson. She later tried a cheaper product from a third-party seller. Bobbi said it made her sick and didn't work. The FDA's warning is specific: compounded GLP-1 drugs are not FDA-approved and do not receive its premarket review for safety, effectiveness, and quality.

If TeamCare won't pay, the answer isn't a mystery vial. It's one of the FDA-approved options further down this page.

Will the October 1 Caremark change make TeamCare cover Zepbound?

Answer: Not automatically. CVS Caremark announced that Zepbound will return as a preferred option on its most common commercial formularies on October 1, 2026. Plans can customize coverage. That announcement does not itself remove the weight-loss exclusion in the TeamCare documents we reviewed.

You may have seen the headlines. They're true: CVS announced on May 28, 2026 that Zepbound returns October 1.

But read CVS's own wording closely. The change is meant to help "plan sponsors who elect to provide coverage of those medications." The reviewed TeamCare documents exclude prescriptions for weight loss.

Think of it as two locks on the same door:

• Lock 1 is TeamCare's plan rules. This is the weight-loss exclusion in the plan document. A Caremark announcement is not a TeamCare benefit amendment.
• Lock 2 is Caremark's drug list. This is what the October 1 announcement changes for the affected formularies.

This is our comparison of the reviewed plan documents, posted July formulary, and CVS announcement. We did not find a TeamCare amendment removing the exclusion in the sources reviewed.

What to do now:

• If your Zepbound is for weight loss, don't put your plan on hold based only on the October 1 headline. Ask whether TeamCare has issued an amendment that applies to you. If the exclusion remains, go to your cash options.
• If it's for sleep apnea, ask about coverage now, then ask whether the requirements change on October 1. You don't need to wait to get the current rule in writing.

Does TeamCare cover Zepbound for sleep apnea or diabetes?

Answer: Sleep apnea is a separate question worth asking, not a confirmed workaround. The FDA approved Zepbound in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity. We couldn't confirm TeamCare's criteria for that use. For type 2 diabetes, Mounjaro contains the same active ingredient and is on TeamCare's posted drug list, but you still need a personal coverage check.

If you have obstructive sleep apnea

Obstructive sleep apnea (OSA) means your breathing stops and starts while you sleep because your airway gets blocked. In December 2024, Zepbound became the first medicine the FDA approved for it. That approval is for moderate-to-severe OSA in adults with obesity.

Two facts make this worth a phone call:

1. The plan exclusion is written about drugs prescribed for weight loss. An OSA prescription has a different medical purpose. TeamCare still has to confirm which benefit rules apply.
2. Caremark's list discusses exceptions when preferred drugs are not clinically appropriate. That means they aren't medically right for your condition. The Zepbound row names four preferred alternatives, including Wegovy. Wegovy's current FDA-approved label does not include sleep apnea. Ask whether a diagnosis-specific exception is available under your plan; the general list does not promise one.

That's a real argument, not a promise. Ask this, word for word:

"Does my plan cover Zepbound when it's prescribed for my diagnosed obstructive sleep apnea? Please check that use specifically. Which benefit rule applies, and what records does my doctor need to send?"

Ask whether they need your sleep study report. Then send your doctor the answer.

Use only your real diagnosis. Never change a diagnosis to get coverage. It can cost you the claim and your trust with the plan.

For the bigger picture, see Does Insurance Cover Zepbound for Sleep Apnea?

If you have type 2 diabetes

Zepbound isn't FDA-approved for diabetes. Mounjaro is. Both contain tirzepatide, but they are separate branded products with different approved uses. Mounjaro is listed in the diabetes section of TeamCare's July 2026 Caremark list. Ozempic, Rybelsus, Trulicity, and liraglutide are listed there too. A listing does not confirm your claim will be paid. (Mounjaro label; posted drug list, PDF page 4.)

Ask your doctor whether Mounjaro fits. Ask Caremark which diagnosis records and PA criteria apply to your plan. See our Mounjaro Savings Card guide for costs.

If TeamCare covers your shot, which cost rules matter?

Check these before treating a pharmacy quote as your final cost:

• Separate injectable cap. TeamCare's FAQ describes a yearly out-of-pocket limit for injectable drugs. The reviewed active-plan schedule sets a $1,000 limit for plans other than U5 and U7, which follow Kaiser rules. Your share of covered TeamCare RX prescriptions counts toward that threshold; after it is met, covered injectable drugs are paid at 100% for the rest of the calendar year. Cash spent on an excluded Zepbound prescription does not turn into a covered expense. Confirm your own Plan Benefit Profile. (Active plan, §20.08, PDF page 137.)
• Savings card. Lilly's Zepbound Savings Card can lower the single-dose pen cost to as little as $25 for eligible people with commercial coverage. It is not a guaranteed $25 copay: the covered-pen offer saves up to $100 per 28-day fill, with a $1,300 annual savings limit and up to 13 fills. Government coverage is excluded from that offer. The current card ends December 31, 2026.
• Third-fill rule. TeamCare has a 90-day maintenance-drug rule, but its plan documents list injectable drugs as exempt from that maintenance-drug classification. Do not assume Zepbound or Mounjaro gets a 50% third-fill penalty just because it is used long term. Ask Caremark about the fill size and pharmacy rules for your approved prescription. (Active plan, §20.01(f)(3), PDF page 117.)

How do I check my own TeamCare Zepbound coverage?

Answer: Log in at Caremark and look up Zepbound under your plan, or call CVS Caremark Customer Care at 1-888-483-2650. For plan rules, call TeamCare at 1-800-TEAMCARE (1-800-832-6227) or send a secure message through the MyTeamCare Message Center. Ask about your exact prescription and the reason it's prescribed. (TeamCare prescription benefits; TeamCare claim help.)

It beats any website, including this one.

1. Have these ready:

• your TeamCare ID card;
• the exact drug form—Zepbound single-dose pen, KwikPen, or vial—and strength;
• the reason it's prescribed.

1. Check online. Sign in at Caremark and open Plan & Benefits → Plan Summary to review your benefit. Use the drug-cost and coverage lookup for your exact prescription.
2. Call with the script below. Use Caremark for drug-list questions and TeamCare for plan-rule questions.
3. Write everything down. Keep the call reference and request the written rule or denial. Call notes help you keep track; they do not replace a written coverage decision.

The TeamCare Zepbound call script

"I'm checking my benefits before paying for Zepbound. Please help me confirm: 1. Which plan document and amendments apply to me? 2. Is Zepbound covered for the reason my doctor is prescribing it? 3. If not, is it a benefit exclusion, a drug-list restriction, or a prior authorization requirement? 4. What criteria and records would my doctor need to send? 5. Which form, strength, quantity, and pharmacy should I check for price? 6. If I'm denied, where do I get the written reason, the appeal instructions, and the deadline?"

Your call notes

Keep this sheet: Copy the script and table into your notes, or print this page. No email, upload, or signup is needed to use it. Keep your member ID and medical records out of public messages.

Don't want to make the call? Ro's free GLP-1 Insurance Coverage Checker (affiliate link) contacts your plan for you and emails a report on the Zepbound single-dose pen, Wegovy pen, and Ozempic pen. It can't check the Zepbound KwikPen, Foundayo, or the Wegovy pill. Ro advertises a $50 Ro credit for new accounts—not a cash payment. The report is not a prescription, a PA submission, or an approval. We checked the service description, not a live TeamCare account.

What if TeamCare denied my Zepbound?

Answer: Start with the reason written on your denial. TeamCare's general claim process allows a written appeal within 180 days of the original decision, then a second appeal within 180 days after receiving the first appeal denial. For a pharmacy case, confirm who handles the appeal and follow the instructions on your actual notice. (TeamCare appeal process.)

An appeal works best when it answers the exact reason you were given.

Match your next move to the denial reason

Our GLP-1 Denial Decoder explains exclusions versus prior authorizations in more detail.

How to file a TeamCare appeal

First, check the destination. A pharmacy rejection may have Caremark-specific steps. Ask which process handles your case before you mail anything. The steps below are from TeamCare's general appeal page:

1. Use TeamCare's form or your own letter. The form is under Claim Appeals in your MyTeamCare account. A letter needs:

• the member's name, address, and ID number;
• the claim number;
• the patient's name and relationship to the member;
• the date of loss or service shown on the claim;
• the exact reason you disagree.

1. Include your denial letter or Explanation of Benefits, plus any medical records that support you.
2. Send it through the Message Center, or mail it to: Research & Correspondence Department, TeamCare, A Central States Health Plan, PO Box 5126, Des Plaines, Illinois 60017-5126. Fax: 1-847-518-9794.
3. If both appeals are denied, TeamCare notes the right to bring a civil action under Section 502(a) of ERISA. An independent external review is another possible step for eligible denials—not every benefit exclusion. The non-grandfathered plan's §10.06 sets out those rules. Ask which review rights and deadlines apply to your notice.

Build your appeal letter with our free template (no email needed) →

How much does Zepbound cost if TeamCare won't pay?

Answer: LillyDirect's published self-pay prices are $299 for 2.5 mg, $399 for 5 mg, and $449 with the higher-dose offer for 7.5–15 mg per 28-day supply. Your first higher-dose purchase receives the offer. To keep it, complete your next refill purchase within 45 days of the previous prescription's delivery or receipt. Without the offer, higher doses cost $499–$699. (Lilly's terms.)

Zepbound cash prices by dose (vials or KwikPen)

Source: Lilly's Zepbound Self Pay Journey terms, checked September 22, 2026. One supply is 28 days: four single-dose vials or one four-dose KwikPen. The 45-day condition applies to the higher-dose discount, not the regular 2.5 mg and 5 mg prices. Taxes and fees may apply.

52 weeks is 13 fills, not 12

Each fill lasts 28 days. Thirteen fills cover 364 days—52 weeks, not quite a full calendar year. Here's one possible budget if your prescriber moves you from 2.5 mg to 5 mg, then to higher doses and a maintenance dose priced at $449:

• $299 + $399 + (11 × $449) = $5,637 for 52 weeks of medicine.

That is a price example, not a dosing plan. If your prescriber instead keeps you at 5 mg after the starting fill, the same 52-week calculation is $299 + (12 × $399) = $5,087.

Don't budget off the $299 price. 2.5 mg is a starting dose, not a long-term dose. The labeled maintenance doses for weight loss are 5, 10, or 15 mg; for OSA they are 10 or 15 mg. Your prescriber chooses based on your response and side effects. (Prescribing information.)

These are our calculations using current LillyDirect prices, assuming each required higher-dose refill purchase meets the offer terms. They are not a promise that today's prices or offers will last into 2027.

What else to know before you buy

• Needles are extra. The KwikPen needs a new pen needle for each weekly shot. Vials need syringes and needles. Lilly sells supplies at checkout, or you can buy them at a pharmacy.
• You have three places to buy:
• LillyDirect (vials or KwikPen);
• retail pharmacies, using Lilly's KwikPen Self-Pay Savings Card, which works for the KwikPen only;
• telehealth programs that offer access to Lilly's self-pay prices, with any care fees billed separately.
• The retail card has its own limits. Its prices are advertised as "as low as," subject to savings caps. The current KwikPen card allows up to 11 fills per calendar year and ends December 31, 2026. Do not treat the 13-fill LillyDirect budget above as a promise of 13 retail-card fills. Card purchases cannot be submitted to insurance for reimbursement or counted toward its deductible under the card's terms.
• Prefer the single-dose autoinjector? Lilly also lists a separate offer as low as $499 per 28-day fill for eligible commercially insured people whose plan does not cover Zepbound. That is a different device and card from the $299–$449 vial/KwikPen options. (Lilly's savings terms.)
• You still need a prescription. More on that next.

What should you budget each month at a $449 dose?

A $449 prescription fill lasts 28 days. A monthly care membership follows its own billing cycle. Adding the two and calling it a recurring monthly total understates the medicine budget.

For a prescribed 10 mg or 15 mg maintenance dose at $449 per fill, 13 fills cost $5,837. Spread that across 12 budget months and the medicine alone is $486.42 per month on average.

Our calculation combines 52 weeks of medicine with 12 months of care at Ro's published fees. It excludes the first-month promotion, supplies, taxes, and other charges. The annual fee is paid upfront, not as twelve $74 payments. This is a budgeting comparison, not a checkout quote or a guarantee of future prices.

Ro's $39 introductory care fee plus one $299 starting-dose fill is $338 before other charges. That is a starting payment, not the ongoing cost.

What's the easiest way to get Zepbound if TeamCare won't pay?

Answer: If your own doctor will write the prescription, send it to LillyDirect or use Lilly's KwikPen savings card at a pharmacy. That avoids adding a telehealth membership. If you don't have a prescriber, an online program like Ro can evaluate you for Zepbound and offers the same published LillyDirect medicine prices, plus a membership fee. A clinician still has to decide whether treatment fits.

Sources: Lilly, Ro pricing, and Success by Sesame, checked September 22, 2026. Medication is separate from both services' care fees. The "best for" column is our fit judgment, not a tested service outcome.

When Ro fits a TeamCare member paying cash

Let's be straight about one thing first.

Ro cannot make TeamCare remove a weight-loss exclusion. Its care fee buys medical care and support, not guaranteed insurance approval. And if you already have a doctor who'll prescribe, going straight to LillyDirect avoids Ro's added membership fee (see LillyDirect vs Ro).

For cash-pay care, Ro offers:

• the published LillyDirect self-pay prices for Zepbound;
• an online medical review without needing TeamCare to cover the medicine;
• help with dose changes and side effects along the way;
• access to pill options if your clinician agrees a switch makes sense. Some start at $149, but dose changes can raise that price.

For someone who's been bounced between TeamCare, Caremark, and a pharmacy counter, that last part matters.

What Ro states—and what we actually checked

Sources: Ro pricing, Ro's Zepbound page, insurance support, and terms of use, checked September 22, 2026.

Before you prepay: Ro Body renews automatically. Its terms require cancellation at least 48 hours before renewal to avoid the next membership charge; paid membership fees are generally nonrefundable. You can cancel in your account under the program's details. Prescription purchases are generally final. The first-month refund for being found ineligible is a separate policy. (Membership terms; returns and refunds.)

Does that sound like your situation? See Ro's Zepbound options and medical review process → (affiliate link) Get started for $39, then as low as $74/month with annual plan paid upfront. Medication is billed separately.

Would you rather choose your own clinician by name? Read our Sesame Care review for current fees.

Is there a cheaper FDA-approved option than Zepbound?

Answer: Yes. Paying cash, the Wegovy pill and Foundayo pill each start at $149 for a 30-day supply. Eligible new Wegovy-pen patients can pay $199 for each of the first two qualifying starter fills under the current offer. The reviewed TeamCare weight-loss exclusion applies to these drugs when prescribed for weight loss too, so switching brands alone does not unlock that benefit.

The plan rule is about why a drug is prescribed, not which brand it is. Under the reviewed terms, Wegovy for weight loss is excluded just like Zepbound. So if you're paying cash anyway, compare cash prices.

Sources checked September 22, 2026: NovoCare's Wegovy terms, Lilly's Foundayo terms, and Lilly's Zepbound terms. These are medicine prices, not all-in care prices.

For Foundayo's two highest strengths, the first purchase gets the $299 offer. To keep it, complete the next refill purchase within 45 days of the previous delivery or receipt. Don't choose a treatment budget based only on a temporary starting price.

The trade-off: cheaper isn't better if it doesn't work for you. In SURMOUNT-5, published in the New England Journal of Medicine in 2025, average weight loss at 72 weeks was 20.2% with tirzepatide versus 13.7% with semaglutide. The Lilly-funded, open-label trial enrolled 751 adults without type 2 diabetes. It compared tirzepatide 10 or 15 mg with semaglutide 1.7 or 2.4 mg—not either pill, Foundayo, or Wegovy HD 7.2 mg. Those averages are not a promise of your result. (Study; Lilly's full-results report.)

Pills skip the needle and cost less to start. Your prescriber can help you weigh it. See Is the Wegovy Pill Worth It? and Is Foundayo Worth It?

Compare Ro's pill prices and care fees → (affiliate link)

About compounded tirzepatide: You'll see ads for cheaper "compounded tirzepatide." Compounded drugs are not FDA-approved and are not the same as Zepbound. The FDA says they should be used only when a patient's medical needs cannot be met by an FDA-approved drug. If you're weighing that path, read Compounded vs Name-Brand GLP-1 first. (FDA guidance.)

I'm a TeamCare retiree on Medicare. Can I get Zepbound for $50?

Answer: Possibly. Medicare's GLP-1 Bridge provides eligible people with $50 fills from July 1, 2026, through December 31, 2027. It includes Zepbound KwikPen, Wegovy, and Foundayo—not Zepbound single-dose pens or vials. Employer and union retiree Medicare drug plans, called EGWPs, are an eligible plan type, but membership alone does not qualify you. (CMS program rules.)

The Bridge operates outside the regular Part D benefit. TeamCare's weight-loss exclusion does not decide Bridge eligibility.

You need an eligible Part D plan, must be at least 18, and need a weight-management prescription with ongoing nutrition and physical-activity support. CMS uses your BMI when you first started GLP-1 treatment—not just your current weight. BMI is a number based on height and weight.

For this program, uncontrolled blood pressure means the top number is above 140 or the bottom number is above 90 despite two blood-pressure medicines. These are CMS's criteria, not the broader criteria for getting a GLP-1 prescription.

Some people must use regular Part D instead. CMS directs people with type 2 diabetes, moderate-to-severe OSA, or a qualifying noncirrhotic MASH diagnosis—a form of liver disease—to their Part D plan, even if they meet the Bridge BMI rules. Its prescriber fact sheet also says a patient who has received a GLP-1 through Part D must use the Part D process rather than Bridge. That does not guarantee the Part D plan will approve the prescription or charge $50.

To start: Your prescriber sends the prescription to a pharmacy with instructions to bill Bridge for weight management. The pharmacy submits the claim, then your prescriber completes the required PA process. You do not need to get a regular Part D denial first. Zepbound pen needles are extra. (CMS prescribing steps; CMS provider FAQ.)

See if you qualify for the $50 Medicare Bridge →

What did we actually verify?

Answer: We read the three cited TeamCare plan documents, the July 2026 Caremark list, TeamCare's prescription and appeal pages, CVS's October announcement, FDA material, manufacturer prices, provider terms, and CMS's Bridge rules. Public sources were checked September 22, 2026. We did not see anyone's TeamCare account or claim.

The evidence map, two-lock comparison, call sheet, and budget calculations are our work assembled from those sources. We did not buy medication, test provider care, or obtain an insurance approval for this article.

How we make money: We earn commissions from some providers, including Ro, when readers sign up through our links. This page uses five areas to compare provider fit: clinical legitimacy, care quality, transparency, access, and cost. It does not assign Ro a numerical score or claim a TeamCare-specific success rate.

See something wrong? Tell us through our contact page. Send a public link or describe the issue. Please don't send your insurance card or medical records.

TeamCare Zepbound FAQ

The key distinction stays the same: a drug-list entry is not your coverage decision. Check the prescribed use, your governing plan, and any approval requirements before paying.

Does TeamCare cover Wegovy?

Not for weight loss under the three reviewed plan documents. Wegovy is a preferred drug on the Caremark list TeamCare posts, but the plan rule comes first. Its label also includes reducing major cardiovascular events in adults with established cardiovascular disease and overweight or obesity. Wegovy injection also has accelerated approval for adults with MASH—a liver disease—with moderate-to-advanced scarring (F2–F3) but no cirrhosis. Ask TeamCare about the actual prescribed use; neither indication guarantees coverage. (Posted formulary; Wegovy label.)

Does TeamCare cover Ozempic?

Ozempic appears in the diabetes section of TeamCare's posted drug list, but you still need to check your personal benefits. For weight loss alone, the reviewed plans exclude it. The WSAW member story above concerned loss of Ozempic coverage, not a rule proving every diabetes prescription will be paid. (TeamCare drug list.)

Does TeamCare cover Mounjaro?

Mounjaro is in the diabetes section of TeamCare's July 2026 Caremark list. It is FDA-approved for type 2 diabetes, but a listing is not an approval. Ask Caremark which criteria and records apply to your prescription. (Drug list; Mounjaro label.)

Is TeamCare the same as CVS Caremark?

No. TeamCare is your health plan. CVS Caremark is TeamCare's pharmacy benefit manager, the company that runs the drug side. (TeamCare prescription benefits.)

What is TeamCare's phone number?

TeamCare: 1-800-TEAMCARE (1-800-832-6227). CVS Caremark Customer Care: 1-888-483-2650. Use the number on your current member card if it directs you elsewhere. (TeamCare help; prescription benefits.)

Will TeamCare cover Zepbound after October 1, 2026?

The Caremark announcement alone does not answer that. Weight-loss prescriptions remain excluded under the reviewed TeamCare terms unless the applicable benefit changes. For sleep apnea, ask about the current rules and the October formulary change. We did not verify a TeamCare benefit amendment removing the exclusion. (CVS announcement; plan evidence.)

Can I use the Zepbound Savings Card with TeamCare?

The covered-commercial offer can bring eligible single-dose pen fills as low as $25, subject to savings limits. If your plan does not cover Zepbound, a separate single-dose pen offer starts at $499 for eligible commercially insured patients. Vial and KwikPen self-pay options start at $299, with dose and offer conditions. These are different programs—not one card that guarantees the same price for every form. (Lilly's savings terms.)

Does TeamCare cover the Wegovy pill or Foundayo?

Not for weight loss under the reviewed terms. The exclusion applies to drugs prescribed for weight loss, not just injections. Foundayo does not appear in the July 2026 list we reviewed; that alone is not a complete member-specific coverage decision. Both pills have $149 starting-strength self-pay options for 30 days, with higher prices at other doses. (TeamCare list; Wegovy prices; Foundayo prices.)

Can Ro check my TeamCare coverage for me?

Ro offers a free plan check for the Zepbound single-dose pen, Wegovy pen, and Ozempic pen. It can't check the Zepbound KwikPen, Foundayo, or the Wegovy pill. We verified the published service, not its completion for a TeamCare member. The report is not a PA approval.

Does TeamCare cover weight-loss surgery?

The reviewed active-plan document excludes surgery done mainly for obesity but points to a bariatric-surgery exception. Section 12.04 requires both the procedure and the facility to be preapproved by the plan. Ask TeamCare for your applicable criteria before scheduling. (Active plan, §12.04, PDF page 81.)

What if TeamCare already approved my Zepbound?

Ask for your approval's end date, the renewal rules, and your next-fill price. Don't stop or change your medicine because of a general article. Talk with your prescriber first.

A quick safety note

Zepbound carries a boxed warning about thyroid C-cell tumors seen in rodent studies. Whether it causes these tumors in humans is unknown. Don't use it if you or your family has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Don't use it if you've had a serious allergic reaction to tirzepatide or another ingredient. It should not be combined with another tirzepatide product or a GLP-1 drug. Read the full prescribing information. This page explains coverage and cost. It isn't medical advice.

Still not sure which GLP-1 program is right for you? Take our free 2-minute matching quiz. Find My GLP-1 Path →

Sources (checked September 22, 2026)

• TeamCare Active Plan Documents (Grandfathered and Non-Grandfathered) and Retiree Plan R4 — Forms & Documents. Direct document links and page numbers are in the evidence map.
• CVS Caremark Performance Drug List, Standard Control, July 2026 (106-31697B), as posted by TeamCare — PDF.
• TeamCare — Prescription Benefits, Your Benefits FAQ, and How to Appeal a Claim.
• CVS Health, May 28, 2026 — Zepbound formulary announcement.
• FDA — Zepbound approval for obstructive sleep apnea and concerns with unapproved GLP-1 drugs.
• FDA-approved prescribing information — Zepbound, Mounjaro, and Wegovy.
• Manufacturer prices — Zepbound coverage and savings, Zepbound card terms, LillyDirect supplies and access, Foundayo savings, and NovoCare Wegovy savings.
• Ro — Pricing, Zepbound, free insurance checker, insurance support, membership terms, and returns and refunds.
• Sesame — Online weight-loss program.
• CMS — Medicare GLP-1 Bridge provider information and prescriber fact sheet.
• SURMOUNT-5 — New England Journal of Medicine, 2025, and Lilly's full-results report.
• WSAW-TV, September 23, 2025 — TeamCare member's Ozempic coverage experience.